Register Login

Cyteir Therapeutics (CYT)

  • Event
  • June 06, 2022, 12:34 UTC

(10% Negative) Cyteir Therapeutics, Inc. (CYT) Announces Delay in well Trials for advanced Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Oct. 2, 2025, 4:17 a.m.

    📋 Cyteir Therapeutics, Inc. (CYT) - Clinical Trial Update

    Filing Date: 2022-06-06

    Accepted: 2022-06-06 08:34:54

    Event Type: Clinical Trial Update

    Event Details:

    Cyteir Therapeutics (CYT) Announces Clinical Trial Update Cyteir Therapeutics (CYT) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: well, meeting
    • Diseases/Conditions: advanced, Chicago
    • Clinical Stage: Phase 2, Phase 1 study
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Pandemic-Related Challenges, Patient Enrollment, Regulatory Process
    • Collaboration: Cyteir Therapeutics, Inc.
      • expected in second half of 2022
      • Expected in 2H 2022

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Cyteir Therapeutics
    • CIK: 0001662244
    • Ticker Symbol: CYT
    • Period End Date: 2022-06-05
    • Document Type: 8-K

Search

News categories